Cargando…
In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression
Mouse models have dramatically improved our understanding of cancer development and tumor biology. However, these models have shown limited efficacy as tractable systems for unbiased genetic experimentation. Here, we report the adaptation of loss of function screening to mouse models of cancer. Spec...
Autores principales: | Meacham, Corbin E., Ho, Emily E., Dubrovsky, Esther, Gertler, Frank B., Hemann, Michael T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756700/ https://www.ncbi.nlm.nih.gov/pubmed/19783987 http://dx.doi.org/10.1038/ng.451 |
Ejemplares similares
-
A genome-scale in vivo loss-of-function screen identifies Phf6 as a lineage-specific regulator of leukemia cell growth
por: Meacham, Corbin E., et al.
Publicado: (2015) -
A Global In Vivo Drosophila RNAi Screen Identifies a Key Role of Ceramide Phosphoethanolamine for Glial Ensheathment of Axons
por: Ghosh, Aniket, et al.
Publicado: (2013) -
A Kinome RNAi Screen Identified AMPK as Promoting Poxvirus Entry through the Control of Actin Dynamics
por: Moser, Theresa S., et al.
Publicado: (2010) -
In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
por: Sa, Jason K., et al.
Publicado: (2015) -
GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update
por: Schmidt, Esther E., et al.
Publicado: (2013)